A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen
Clinical trial NCT02963103 · TERMINATED
Trial details
- NCT number
- NCT02963103
- Sponsor
- Astellas Pharma Korea, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2012-10-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.